Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effects.

ABSTRACT:

SUBMITTER: Hu C 

PROVIDER: S-EPMC12278401 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature